Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia (Q46236668)

20 December 2017

title

Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia (English)

1 reference

20 December 2017

author name string

Hideyuki Koharazawa

1

1 reference

20 December 2017

Heiwa Kanamori

2

1 reference

20 December 2017

Rika Sakai

3

1 reference

20 December 2017

Chizuko Hashimoto

4

1 reference

20 December 2017

Sachiya Takemura

5

1 reference

20 December 2017

Michiko Hattori

6

1 reference

20 December 2017

Jun Taguchi

7

1 reference

20 December 2017

Katsumichi Fujimaki

8

1 reference

20 December 2017

Naoto Tomita

9

1 reference

20 December 2017

Hiroyuki Fujita

10

1 reference

20 December 2017

Shin Fujisawa

11

1 reference

20 December 2017

Hiroshi Harano

12

1 reference

20 December 2017

Koji Ogawa

13

1 reference

20 December 2017

Shigeki Motomura

14

1 reference

20 December 2017

Atsuo Maruta

15

1 reference

20 December 2017

Yoshiaki Ishigatsubo

16

1 reference

20 December 2017

publication date

1 November 2008

1 reference

20 December 2017

published in

Leukemia & Lymphoma

1 reference

20 December 2017

volume

49

1 reference

20 December 2017

issue

11

1 reference

20 December 2017

page(s)

2133-2140

1 reference

20 December 2017

Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Analysis of 20-year follow-up study of LVP regimen for adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Age, sex, haemoglobin level, and white cell count at diagnosis are important prognostic factors in children with acute lymphoblastic leukemia treated with BFM-type protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802464711

10.1080/10428190802464711

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19021056

1 reference

20 December 2017